Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01362179 · ClinicalTrials.gov registry record
National Marrow Donor Program Long-Term Donor Follow-Up
A clinical trial, sponsored by Center for International Blood and Marrow Transplant Research.
- Completed
- Registry status
- 21,974
- Enrollment target
NCT01362179 is a clinical trial that has completed, run by Center for International Blood and Marrow Transplant Research. The registered enrollment target is 21,974 participants.
The verdict
NCT01362179 has completed, sponsored by Center for International Blood and Marrow Transplant Research.
- COMPLETED
- Registry status
- 21,974 participants
- Enrollment target
Study Summary
This is an observational study of unstimulated bone marrow (BM) and filgrastim-mobilized peripheral blood stem cell (PBSC) donors. The primary goal is to evaluate the hypothesis that the incidence of targeted malignant, thrombotic and autoimmune disorders after unrelated hematopoietic stem cell donation are similar between unstimulated BM and filgrastim-mobilized PBSC donors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21,974 participants |
| Start Date | 2010-10 |
| Est. Completion | 2020-10-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01362179
The ClinicalTrials.gov registry entry for NCT01362179 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21,974 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Center for International Blood and Marrow Transplant Research, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01362179 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01362179 about?
NCT01362179 is a clinical study titled "National Marrow Donor Program Long-Term Donor Follow-Up". This is an observational study of unstimulated bone marrow (BM) and filgrastim-mobilized peripheral blood stem cell (PBSC) donors. The primary goal is to evaluate the hypothesis that the incidence of targeted malignant, thrombotic and autoimmune disorders after unrelated hematopoietic stem cell dona...
What is the current status of trial NCT01362179?
This trial is currently completed. The enrollment target is 21,974 participants. The study started on 2010-10. Estimated completion is 2020-10-15.
Who is sponsoring clinical trial NCT01362179?
This trial is sponsored by Center for International Blood and Marrow Transplant Research, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.